Clinical Trial

Safety and Efficacy of JMKX000189 for Chemotherapy-Induced Peripheral Neuropathy

Name: Safety and Efficacy of JMKX000189 for Chemotherapy-Induced Peripheral Neuropathy — clinical trial record (NCT07601386)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This Phase Ib clinical trial aims to evaluate the safety, tolerability, and preliminary efficacy of JMKX000189 tablets in participants with chemotherapy-induced peripheral neuropathy (CIPN).

Trial Details

NCT Number	NCT07601386
Lead Sponsor	Shanghai Jeyou Pharmaceutical Co., Ltd.
Conditions	CIPN - Chemotherapy-Induced Peripheral Neuropathy
Enrollment	18 participants
Start Date	2026-05-10
Primary Completion	2027-06-20 (estimated)
Study Completion	2027-06-20 (estimated)
Updated on ClinicalTrials.gov	2026-05-22